From From the Innovator’s Workbench with Gary Guthart, PhD · · Stanford Biodesign
“Every company runs on an enormous number of KPIs... sometime around 2010 or 2011 I said let's make sure we are measuring our performance against what our customers care about which is the quintuple and be serious about it — go do those measurements and then if we're wrong work on it and if we're right we'll advocate for it.”
On , Gary Guthart, Executive Chair at Intuitive Surgical, Inc, spoke about performance metrics during From the Innovator’s Workbench with Gary Guthart, PhD on Stanford Biodesign.
During Intuitive Surgical’s Q1 2025 earnings call on April 1, 2025, Gary Guthart addressed the impact of trade policy changes on the company. He stated that the company’s first priority is to assure product supply to customers globally and that it does not plan “reflexive changes to our pricing in the dynamic near-term environment.” He added that a second priority will be to optimize production costs and rebalance product flows within the existing manufacturing and supply chain footprint as policies stabilize. Guthart attributed roughly half of a 170-basis-point impact in 2025 to U.S.-China trade in both directions and about 40% to imports into the U.S. from China, Mexico, and Canada. Guthart said the company is “perceived as part of the solution, not part of the problem” and that customers continue to adopt its systems because they see economic and outcome benefits. He described the total cost to treat per patient episode for a well-run program as “outstanding,” adding that hospitals achieve better outcomes, higher satisfaction, and the lowest total cost of care. He closed by reiterating the company’s belief in a “substantial and durable opportunity” to improve surgery and acute interventions, and its vision of care that is less invasive, with earlier disease identification and quicker treatment.